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Depression in Older
Adults With Heart Failure
We read with great interest the study by Gottlieb et al. (1), which
examined an important area in heart failure (HF) management:
depression. The investigators observed that for every 10 years
above the mean age (64 years), “the likelihood of exhibiting
depressive symptoms decreased by 26%.” This is surprising as
depression is rather common in old age. About 20% of the U.S.
population 65 years and older suffer from depression, compared
with 7% in younger adults (2,3).
Many of these older adults suffer from subsyndromal or atypical
depression, which is much more common in old age, more difficult
to diagnose, and is as distressing and disabling as major depression
(2– 4). The vast majority of HF patients are 65 years or older, many
have preserved systolic function, and they receive care from
generalist physicians in nonacademic settings. The results of this
interesting study of depression in relatively younger male HF
patient with systolic dysfunction receiving care from a cardiology
clinic in an academic setting may not be generalizable to most HF
patients.
Focusing on “relatively young” patients may not be the most
efficient way to screen depression in HF, and certainly not in older
adults. In addition, use of the Geriatric Depression Scale, instead
of the Structured Clinical Interview described in the Diagnostic and
Statistical Manual of Mental Disorders, 3rd edition–Revised (DSM–
III-R) or other diagnostic tools such as Beck Depression Inventory, is more likely to identify depression in older adults (5).
Finally, care settings also likely have significant implications for
appropriate diagnosis and management of depression in older
adults with HF. Older adults with HF should preferably receive
primary care from a generalist physician, in consultation with a
cardiologist (6). The American College of Cardiology/American
Heart Association guidelines for chronic HF has identified this
collaborative model as the most preferred model for HF management (7).
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Influence of Age, Gender, and Race
on Depression in Heart Failure Patients
We applaud Gottlieb and colleagues for devoting attention to
depression and quality of life in heart failure (HF) patients (1). We
are concerned, however, with the investigators’ use of: 1) the Beck
Depression Inventory (BDI) (2) as a sole measure of depression,
and 2) the Medical Outcomes Study, Short Form Health
Survey-36 (SF-36) (3) as a measure of quality of life in HF
patients.
Although there is precedent for using the BDI to screen for
depression in HF patients (4,5), we are concerned that the BDI
may be inadequate as a single index of depression in this medically
ill population. Because the BDI was not designed to diagnose or
assess depression in medically ill patient samples, fully one-third of
the scale’s items are somatic in focus, assessing fatigue, appetite,
libido, sleep habits, somatic worry, functional ability, and weight
change—all symptoms consistent with HF. Previous studies of
major depression in HF have used the BDI as a screening
instrument before using a diagnostic interview such as the Diagnostic Interview Survey (DIS) (6) to diagnose major depression
(4,5). Without a diagnostic interview for depression and/or a
concurrent, nonsomatic measure of depression (e.g., the Hospital
Anxiety and Depression Scale) (7), using only the BDI to assess
depression poses a potential threat to construct validity in these
symptomatic HF patients. In their study, Gottlieb et al. (1) further
operationalized depression as a BDI score ⱖ10. Whereas Beck et
al. (2) categorize BDI scores of 4 to 10 as normal, and scores of 11
to 16 as indicative of mild depression, these cut-off points
represent norms established in a nonmedically ill population.
Thus, classifying stage II to IV HF patients with BDI scores ⱖ10
as depressed, in the absence of a secondary diagnostic or nonsomatic measure of depression, may potentially serve to overestimate
the prevalence of depression in this, by definition, symptomatic
sample.
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Additionally, the SF-36 used by the researchers as an index of
quality of life is, like the BDI, comprised of both mood and
somatic items. The investigators report a significant correlation
between the BDI and the SF-36; thus, they conclude that
depression is associated with lower quality of life in HF patients.
The overlapping domain items in the BDI and SF-36, however,
may potentially confound this correlation, as the statistical association might, at least in part, reflect the degree to which the scales
themselves correlate.
Depression and quality of life in patients with HF are significant
public health issues that clearly warrant further investigation. As
scientists, we must successfully grapple with the thorny issues of
construct and scale validity within this population (e.g., “what is
the nature of depression in HF?” “what is a validated measure of
depression in HF?”) if our research is to advance both the science
and the standard of care for HF.
*Ronald Freudenberger, MD
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REPLY
We agree with the comments of Dr. Fauchier regarding our recent
study (1) suggesting that many factors influence the prevalence of
depression in patients with congestive heart failure (HF). However, it should not be assumed that a patient with a longer duration
of symptoms is more likely to be depressed. It is just as likely that
patients may become more adjusted to their situation, resulting in
less depressive symptoms. Although it is difficult to determine
duration of symptoms reliably, we did not attempt to do so; thus,
we encourage others to test these hypotheses.
As indicated by our previous study referenced by Dr. Fauchier,
we believe that defibrillators (ICDs) may have important psychological consequences (2). Because more ICDs are likely to be
implanted owing to the SCD–HeFT study (3), it is crucial to
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understand their psychological impact. For this reason, we obtained and are analyzing data from a substudy of SCD–HeFT
addressing this issue.
We also agree with Dr. Ahmed that a collaborative model of
treatment should be used in all patients with congestive HF. It is
thus important that primary care physicians (including gerontologists) understand that patients who are still symptomatic despite
treatment should be referred to a specialist in HF regardless of the
patient’s age.
One can debate Dr. Ahmed’s assertion that depression is more
common in the elderly; the data he references suggest that major
depression is less common, whereas “minor” depressive symptoms
may be more common (4,5). The current study involved many
patients under age 65 years, dictating use of an instrument
appropriate for a broad age range. However, we do not consider
determination of the exact prevalence of depression in various
groups as the important result of our study. Rather, our findings
emphasize the difference in patterns of depression between patients
with severe HF and the general population. Furthermore, we
demonstrated (in the wide range of patients studied) that depression, as quantified by standard questionnaires, was extremely
common in all groups. In our sample, 53% of those under age 65
years and 43% of those age 65 years and older reported symptoms
of depression.
As Dr. Freudenberger and colleagues are well aware, the
interaction of depression and symptoms of HF is complex; three of
the co-authors of our manuscript (S.S.G., M.L.F., S.R.) coauthored a publication with two of them (R.F., C.S.), which
demonstrated that patients with depression believe themselves to
be more ill even when there are no objective criteria supporting this
perception (6). Furthermore, as Dr. Ahmed’s letter points out,
diagnosis of depression is affected by many variables, including age,
gender, and race. Indeed, any diagnosis of depression is, by
definition, arbitrary. Thus, determination of the exact prevalence
of depression can be debated ad nauseam, leading to obfuscation of
the important points: depression is common and diagnosis may be
impacted by various demographic factors. Although it is unreasonable to expect all patients with HF to be screened by psychiatrists, the Beck-Depression Inventory (BDI) is an excellent screening tool, and awareness of the prevalence of depression can lead to
treatment and improved quality of life.
Dr. Freudenberger and colleagues are of course correct that
physical components of the scales might be influenced by the
physical limitations of HF. It is for this reason that we reported the
various subscales of both the Minnesota Living With Heart
Failure (MLWHF) and SF-36 questionnaires. Both the emotional
and physical subscales of the MLWHF (a disease-specific qualityof-life questionnaire) exhibited extremely close correlations with
the BDI. Similarly, various components of the SF-36, including
those not influenced by physical limitations, strongly correlated
with the BDI.
Depression may contribute to symptoms in any HF patient.
Treatment efficacy will probably vary based upon age, gender, race
or other factors, and these variables need to be assessed when
intervention trials are performed. We now know, however, that
consideration of the possible impact of depression upon symptoms
is essential for all patients with HF.
*Stephen S. Gottlieb, MD, FACC
Sue Ann Thomas, RN, PhD, FAAN
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